Abstract:Objective Indoleamine 2,3-dioxygenase(IDO1)played a major role in tumor escape and acquisition of immune tolerance.IDO1 inhibitor get lots of focus on cancer immunological therapeutic research.The experiment′s aim is to study the IDO1 inhibitory activity of the synthesized novel IDO1 inhibitor in LLTC transfected human and murine IDO1.Method Detect the characteristic of IDO1 expression in LLTC,LLTC transfected human IDO1 and murine IDO1 cell lines after treatment of 0,5,10 and 100 ng/mL IFN-γ.Determine the IDO1 inhibitory activity and cellular toxicity of 4-Phenylimidazole,Menadione and novel compound.Result There is no expression of human and murine IDO1in wild type LLTC,even after treatment with murine IFN-γ.LLTC cell lines transfected recombinant IDO1 of murine and human can produce constitutive and specific murine IDO1 and human IDO1 respectively with or without IFN-γ treatment.4-phenylimidizole exist different potent(P<0.05) in inhibition activity in LLTC cell lines transfected recombinant IDO1 of murine and human.Menadione has similar IDO1 inhibitory activity(P>0.05)in LLTC cell lines transfected recombinant IDO1 of murine and human.4-amino-N-(3-chloro-4-fluorobenzyl)-N′-hydroxy-1,2,5-oxadiazole-3-carboximidamide is an IDO1 inhibitor which has manifest powerful nanomolar IE50 in LLTC cell lines transfected recombinant IDO1 of murine and human,but there are difference between LLTC-hIDO1 and LLTC-mIDO1 cell lines in the inhibitory activities(P>0.05).4-Phenylimidazole is one of non-cytotoxity IDO1 inhibitor.Menadione has makeable toxicity in both LLTC-hIDO1 and LLTC-mIDO1 cell lines but there are no significant difference(P>0.05).The cellular toxicity of 4-amino-N-(3-chloro-4-fluorobenzyl)-N′-hydroxy-1,2,5-oxadiazole-3-carboximidamide show the lowest toxicity versus to the other two.Conclusion 4-amino-N-(3-chloro-4-fluorobenzyl)-N′-hydroxy-1,2,5-oxadiazole-3-carboximidamide have potent of IDO1 inhibitory activity.It will be used as the new strategy in cancer immunological therapy which is hopefully implemented in clinical translation.

THE IN VITRO INFLUENCE OF INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR:4-AMINO-N-(3-chloro-4-fluorobenzyl)-N′-HYDROXY-1,2,5-OXADIAZOLE-3-CARBOXIMIDAMIDE ON MURINE LUNG CANCER CELL LINES

Synthesis and biological activity evaluation of novel indoleamine 2,3-dioxygenase 1 inhibitors

Inhibition Mechanism of Indoleamine 2, 3-Dioxygenase 1 (IDO1) by Amidoxime Derivatives and Its Revelation in Drug Design: Comparative Molecular Dynamics Simulations

Advances in Indoleamine 2, 3-Dioxygenase 1 Inhibitors

Design, Synthesis And Biological Evaluation Of Novel 1,2,5-Oxadiazol-3-Carboximidamide Derivatives As Indoleamine 2, 3-Dioxygenase 1 (Ido1) Inhibitors

Computational study on new natural compound inhibitors of indoleamine 2,3-dioxygenase 1

Discovery of imidazoleisoindole derivatives as potent IDO1 inhibitors: Design, synthesis, biological evaluation and computational studies.

Design, synthesis and biological evaluation of bicyclic carboxylic acid derivatives as IDO1 inhibitors

Design, Synthesis and Antitumor Study of a Series of N-Cyclic Sulfamoylaminoethyl Substituted 1,2,5-Oxadiazol-3-amines As New Indoleamine 2, 3-Dioxygenase 1 (IDO1) Inhibitors.

Progress in Development of Small Molecule Inhibitors Targeting Indoleamine 2,3-Dioxygenase

Design, Synthesis and Biological Evaluation of 2,5-Dimethylfuran-3-carboxylic Acid Derivatives As Potential IDO1 Inhibitors.

Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy

Indoleamine 2,3-dioxygenase (Ido) inhibitors and their nanomedicines for cancer immunotherapy

Inhibitory Investigation of Niacin Derivatives on Metalloenzyme Indoleamine 2,3-Dioxygenase 1 for Its Immunomodulatory Function

Development of Indoleamine 2,3-Dioxygenase 1 Inhibitors for Cancer Therapy and Beyond: A Recent Perspective

Recent Discovery of Indoleamine-2,3-dioxygenase 1 Inhibitors Targeting Cancer Immunotherapy.

Discovery of a potent apo-IDO1 inhibitor for cancer immunotherapy

Discovery of Phosphonamidate IDO1 Inhibitors for the Treatment of Non-Small Cell Lung Cancer.

Spiro-Oxindole Skeleton Compounds Are Efficient Inhibitors for Indoleamine 2,3-Dioxygenase 1: An Attractive Target for Tumor Immunotherapy

Identification of a Compound Inhibiting Both the Enzymatic and Nonenzymatic Functions of Indoleamine 2,3-Dioxygenase 1

Systematic Study of Imidazoles Inhibiting IDO1 Via the Integration of Molecular Mechanics and Quantum Mechanics Calculations.